Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey

Data de publicação: 01/05/2022

Autores da FMUP

[No abstract available]

Parigi, TL:: Humanitas Univ, Dept Biomed Sci, Milan, Italy

Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
D'Amico, F:: Humanitas Univ, Dept Biomed Sci, Milan, Italy

IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy

Univ Vita Salute San Raffaele, Milan, Italy
Abreu, MT:: Univ Miami, Div Gastroenterol & Hepatol, Dept Med, Ctr Crohns & Colitis,Miller Sch Med, Miami, FL USA
Rubin, DT:: Univ Chicago, Med Inflammatory Bowel Dis Ctr, Chicago, IL USA
Dignass, A:: Goethe Univ, Agaples Markus Hosp, Dept Med, Frankfurt, Germany
Dotan, I:: Rabin Med Ctr, Div Gastroenterol, Petah Tiqwa, Israel

Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
Jairath, V:: Western Univ, Dept Med, London, ON, Canada

Western Univ, Dept Epidemiol & Biostatist, London, ON, Canada
Magro, F:: Universidade. Univ Porto, Dept Biomed, Unit Pharmacol & Therapeut, Fac Med, Porto, Portugal

Sao Joao Univ Hosp Ctr, Dept Gastroenterol, Porto, Portugal
Peyrin-Biroulet, L:: Univ Lorraine, CHRU Nancy, Dept Gastroenterol, Nancy, France

Univ Lorraine, INSERM, NGERE, Nancy, France
Ghosh, S:: Natl Univ Ireland, Univ Coll Cork, Coll Med & Hlth, APC Microbiome Ireland, Cork, Ireland
Danese, S:: IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy

Univ Vita Salute San Raffaele, Milan, Italy

Crohn Disease; Humans; Inflammatory Bowel Diseases; Surveys and Questionnaires; corticosteroid; Crohn disease; Europe; gastroenterology; human; inflammatory bowel disease; Letter; North America; Oceanian; personalized medicine; questionnaire; South America; Crohn disease; inflammatory bowel disease